Pacira Biosciences
PCRX
#6309
Rank
HK$7.78 B
Marketcap
HK$197.81
Share price
0.80%
Change (1 day)
6.50%
Change (1 year)
Categories

Operating Margin for Pacira Biosciences (PCRX)

Operating Margin as of October 2026 (TTM): 2.36%

According to Pacira Biosciences 's latest financial reports and stock price the company's current Operating Margin is 2.36%. At the end of 2025 the company had an Operating Margin of 4.33%.

Operating Margin history for Pacira Biosciences from 2010 to 2026

Operating Margin at the end of each year

Year Operating Margin Change
20254.33%-161.16%
2024-7.09%-160.53%
202311.71%59.7%
20227.33%-53.52%
202115.77%55.39%
202010.15%282.43%
20192.65%-55%
20185.90%-165.5%
2017-9.00%-20.75%
2016-11.36%-406.45%
20153.71%-224.51%
2014-2.98%-95.59%
2013-67.43%-47.78%
2012-129.14%-47.44%
2011-245.70%54.29%
2010-159.25%-16.29%
2009-190.24%-41.6%
2008-325.77%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
Zogenix
ZGNX
-259.55%-11,097.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Recro Pharma
REPH
4.99% 111.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Omeros Corporation
OMER
-467.67%-19,916.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
-79.07%-3,450.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Heron Therapeutics
HRTX
-22.52%-1,054.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Cara Therapeutics
CARA
-879.80%-37,379.66%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.